Congress Agrees On Funding For FDA Enforcement Of Hemp CBD Products

Federal lawmakers have agreed on a $1.4-trillion government-wide 2020 spending package. The package contains two spending bills, one of which touches on hemp-derived CBD and provides the FDA and USDA with $2 million for research, policy evaluation, market surveillance and issuance of an enforcement discretion policy.

Last year saw the longest-running government shutdown in U.S. history. To avoid a repeat in 2020, the House and Senate have settled on an appropriations bill that passed a House vote this week and is expected to clear the Senate soon. 

Fiscal year 2020 began Oct. 1. By that date, lawmakers are expected to enact a federal spending budget that appropriates federal spending funds to all 12 appropriations subcommittees.

Like every year since 1997, an agreement wasn’t achieved by the Oct. 1 deadline, so the government is relying on temporary measures to keep afloat until Dec. 20, when a government shutdown will begin if an agreement is not in place. 

The legislation instructs the FDA to develop a policy of enforcement discretion for hemp products containing CBD. The agency is also instructed to conduct a market-wide research of CBD products and perform a sample study that analyzes products against their labeled contents.

“While providing funding for testing is a positive first step, unfortunately, today’s action falls short of what is needed to protect consumers. The future of the U.S. hemp industry and the farmers and producers who provide it are directly tied to smart regulations for CBD, which includes FDA establishing a safe level of consumption so consumers are protected,” said Daniel Fabricant, Ph.D., the president and CEO of the Natural Products Association.

More resources should be allocated to CBD regulation in order to avoid a public health crisis like the one tied to vaping, in Fabricant's view. 

Photo by Darren Halstead on Unsplash.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.